|
AU2003290333A1
(en)
|
2002-12-24 |
2004-07-22 |
Biofocus Plc |
Compound libraries of imidazo(1,5-a)pyridin-3-yl derivatives and related heterobicycles for targetting compounds capable of binding to g-protein coupled receptors
|
|
EP1664042A1
(en)
*
|
2003-09-03 |
2006-06-07 |
Galapagos N.V. |
IMIDAZO 1,5-a PYRIDINE OR IMIDAZO 1,5-a PIPERIDINE DERIVATIVES AND THEIR USE FOR THE PREPARATION OF MEDICAMENT AGAINST 5-HT2A RECEPTOR-RELATED DISORDERS
|
|
WO2008022060A2
(en)
*
|
2006-08-14 |
2008-02-21 |
Novartis Ag |
Imidazo-pyridine derivatives for modulating protein kinase activity
|
|
BRPI0622054B8
(pt)
*
|
2006-09-22 |
2021-05-25 |
Oxford Amherst Llc |
composto e composição farmacêutica
|
|
IL295053A
(en)
|
2007-03-28 |
2022-09-01 |
Pharmacyclics Llc |
Broton tyrosine kinase inhibitors
|
|
EP2283020B8
(en)
|
2008-05-19 |
2012-12-12 |
OSI Pharmaceuticals, LLC |
Substituted imidazopyr-and imidazotri-azines
|
|
CA2787291C
(en)
*
|
2010-02-08 |
2016-04-19 |
Msd Oss B.V. |
8-methyl-1-phenyl-imidazol[1,5-a]pyrazine compounds
|
|
CA2831356A1
(en)
|
2011-03-31 |
2012-10-04 |
Emblem Technology Transfer Gmbh |
Imidazo [1,2-a]pyridine_compounds for use in therapy
|
|
GB2486038B
(en)
*
|
2011-06-28 |
2013-09-25 |
Andrew Levine |
Speech-to-text conversion
|
|
BR112014001255B1
(pt)
*
|
2011-07-19 |
2019-07-02 |
Merck Sharp & Dohme B.V. |
Composto, uso de um composto, combinação, composição farmacêutica, e, sal farmaceuticamente aceitável de um composto
|
|
JP2014522860A
(ja)
|
2011-07-19 |
2014-09-08 |
メルク・シャープ・アンド・ドーム・ベー・フェー |
Ｂｔｋ阻害剤としての４−イミダゾピリダジン−１−イル−ベンズアミドおよび４−イミダゾトリアジン−１−イル−ベンズアミド
|
|
EP2548877A1
(en)
|
2011-07-19 |
2013-01-23 |
MSD Oss B.V. |
4-(5-Membered fused pyridinyl)benzamides as BTK-inhibitors
|
|
FR2985185B1
(fr)
|
2012-01-04 |
2013-12-27 |
Sanofi Sa |
Utilisation en therapeutique de derives d'imidazopyridine
|
|
JP5985658B2
(ja)
|
2012-01-31 |
2016-09-06 |
ナンジン アルゲン ファルマ カンパニー リミテッドＮａｎｊｉｎｇ Ａｌｌｇｅｎ Ｐｈａｒｍａ Ｃｏ． Ｌｔｄ． |
ブルトンチロシンキナーゼ阻害薬としての環状分子
|
|
WO2014114185A1
(en)
|
2013-01-23 |
2014-07-31 |
Merck Sharp & Dohme Corp. |
Btk inhibitors
|
|
WO2014113942A1
(en)
|
2013-01-23 |
2014-07-31 |
Merck Sharp & Dohme Corp. |
Btk inhibitors
|
|
US20160096850A9
(en)
*
|
2013-08-22 |
2016-04-07 |
Genentech, Inc. |
Alkynyl alcohols and methods of use
|
|
WO2015057992A1
(en)
*
|
2013-10-16 |
2015-04-23 |
Izumi Raquel |
Btk inhibitors for hematopoietic mobilization
|
|
WO2015157955A1
(en)
|
2014-04-17 |
2015-10-22 |
Abbvie Inc. |
Heterocyclic btk inhibit ors
|
|
CN105017256A
(zh)
*
|
2014-04-29 |
2015-11-04 |
浙江导明医药科技有限公司 |
多氟化合物作为布鲁顿酪氨酸激酶抑制剂
|
|
WO2016106652A1
(en)
|
2014-12-31 |
2016-07-07 |
Merck Sharp & Dohme Corp. |
Biarylether imidazopyrazine btk inhibitors
|
|
WO2016106626A1
(en)
*
|
2014-12-31 |
2016-07-07 |
Merck Sharp & Dohme Corp. |
Imidazopyrazine analogs with 3-tertiary carbon substitutions as btk inhibitors
|
|
WO2016106623A1
(en)
|
2014-12-31 |
2016-07-07 |
Merck Sharp & Dohme Corp. |
Benzamide imidazopyrazine btk inhibitors
|
|
MA41614A
(fr)
*
|
2015-02-25 |
2018-01-02 |
Alios Biopharma Inc |
Composés antiviraux
|
|
TW201718572A
(zh)
*
|
2015-06-24 |
2017-06-01 |
普林斯匹亞生物製藥公司 |
酪胺酸激酶抑制劑
|
|
US20190008859A1
(en)
*
|
2015-08-21 |
2019-01-10 |
Acerta Pharma B.V. |
Therapeutic Combinations of a MEK Inhibitor and a BTK Inhibitor
|
|
CN106478633A
(zh)
*
|
2015-08-27 |
2017-03-08 |
正大天晴药业集团股份有限公司 |
一类布鲁顿酪氨酸激酶抑制剂
|
|
US20170071962A1
(en)
|
2015-09-11 |
2017-03-16 |
Acerta Pharma B.V. |
Therapeutic Combinations of a Proteasome Inhibitor and a BTK Inhibitor
|
|
US20170035881A1
(en)
|
2015-10-19 |
2017-02-09 |
Acerta Pharma B.V. |
Therapeutic Combinations of an IRAK4 Inhibitor and a BTK Inhibitor
|
|
CN108602827B
(zh)
|
2015-11-06 |
2021-08-20 |
安塞塔制药公司 |
Bruton酪氨酸激酶的咪唑并吡嗪抑制剂
|
|
KR102416971B1
(ko)
*
|
2016-03-11 |
2022-07-04 |
엔젤 파마슈티칼 컴퍼니, 리미티드 |
브루톤형 티로신 키나제를 조절하기 위한 화합물 및 방법
|
|
JP6715357B2
(ja)
|
2016-06-30 |
2020-07-01 |
杭州三因泰医薬科技有限公司Ｈａｎｇｚｈｏｕ Ｓａｎｙｉｎｔａｉ Ｐｈａｒｍａｃｅｕｔｉｃａｌ Ｔｅｃｈｎｏｌｏｇｙ Ｃｏ．， Ｌｔｄ． |
イミダゾピリジンアミンフェニル誘導体およびその使用
|
|
US11186578B2
(en)
*
|
2016-08-17 |
2021-11-30 |
Shenzhen Targetrx, Inc. |
Substituted pyrrolo[3,2-d]pyrimidines and pyrazolo[4,3-d]pyrimidines as tyrosine kinase inhibitors
|
|
KR102627756B1
(ko)
*
|
2017-03-22 |
2024-01-23 |
쑤저우 바이지부공 파마수티컬 테크널러지 컴퍼니 리미티드 |
브루톤 타이로신 키나제 억제제
|